Study Stopped
too few patients meeting current eligibility criteria
The Effects of Glucose/Ischemic Preconditioning on Reperfusion Injury in Deceased-Donor Liver Transplantation
A Prospective, Randomized Trial to Investigate the Effects of Glucose/ Ischemic Preconditioning Donor Pre-treatment on Reperfusion Injury in Deceased-Donor Liver Transplantation
1 other identifier
interventional
50
1 country
1
Brief Summary
Standard liver retrieval procedures for transplantation from a deceased donor inevitably result in a "reperfusion injury" to the liver tissue. The purpose of this research study is to find out whether treatment of the liver with a "preconditioning" protocol before its removal from the donor will help reduce any of this injury. The "preconditioning" treatment being tested has two components. Firstly, a solution of glucose+insulin is infused and secondly, blood flow to the liver is stopped briefly (10 minutes) and then resumed. Both strategies, individually, have been shown to reduce liver tissue injury in human studies. We hypothesize that combining both strategies will have a clinical benefit to patients and will improve liver function following transplant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Aug 2008
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2008
CompletedFirst Posted
Study publicly available on registry
July 18, 2008
CompletedStudy Start
First participant enrolled
August 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedJuly 25, 2014
June 1, 2012
1.8 years
July 16, 2008
July 24, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reperfusion injury determined by peak AST
first 24 hours post-operative
Secondary Outcomes (3)
Biliary Complications, infection and rejection
first month post-transplantation
graft and patient survival; length of hospital stay; length of ICU stay
30 days and 90 days post-transplantation
Liver ATP and glycogen content; blood cytokine levels; liver gene expression of pro- and anti-apoptotic genes
immediately pre-removal and post- transplantation
Study Arms (2)
1
EXPERIMENTALDeceased liver donors that are randomized to this arm will receive the Glucose/Ischemic Preconditioning pre-treatment intra-operatively prior to starting cold preservation of the organ
2
NO INTERVENTIONNeither donors nor recipients receive any intervention. All procedures will be performed according to our institution's standard of care.
Interventions
A 20% dextrose+insulin infusion is administered to the liver via the mesenteric vein beginning after cannulation of the mesenteric vein and ending immediately prior to flushing with cold preservation fluid. Also, after completion of the visceral dissection but prior to cross-clamping, ischemic precondition will occur. This involves occluding the portal vein and hepatic artery to stop blood flow for 10 minutes, then restoring blood flow for 10 minutes.
Eligibility Criteria
You may qualify if:
- Recipient 18 years of age or older
- Recipient with chronic end-stage liver disease
- Deceased donor liver transplant
- Recipient capable of providing written informed consent
- Whole organ graft from donors aged 60 years or older
You may not qualify if:
- Fulminant liver failure
- Objection by any other member of the retrieval team
- Split-liver grafts
- Donor that has received total parenteral nutrition within 24hr of organ retrieval Donors from whom the pancreas and/or small bowel are also being retrieved
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Health Network (Toronto General Hospital)
Toronto, Ontario, M5G 2N2, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Markus Selzner, M.D.
University Health Network, Toronto
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2008
First Posted
July 18, 2008
Study Start
August 1, 2008
Primary Completion
June 1, 2010
Study Completion
March 1, 2012
Last Updated
July 25, 2014
Record last verified: 2012-06